NBC
CRL icon

Neuberger Berman Canada’s Charles River Laboratories CRL Stock Holding History

Neuberger Berman Canada’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-5,360
Closed -$220K – 236
2013
Q2 		$220K Buy
+5,360
New +$230K 0.04% 267

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PIM
Perkins Investment Management Chicago, Illinois $8.09B AUM 25.47% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
FC
Fairpointe Capital Chicago, Illinois $66.3M AUM 101.32% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Neuberger Berman Canada's CRL Position: Q3 2013 in Review

Neuberger Berman Canada sold out of Charles River Laboratories (CRL) in Q3 2013, closing a stake of 5,360 shares — an estimated $220K sold.

Neuberger Berman Canada first reported a position in CRL in Q2 2013 and held it in 1 quarter. The position peaked at $220K in Q2 2013. 230 funds tracked by Wall St. Rank hold CRL as of Q3 2013.

  • Neuberger Berman Canada reported no remaining Charles River Laboratories position as of Q3 2013 after selling out during the quarter.
  • Neuberger Berman Canada sold 5,360 Charles River Laboratories shares in Q3 2013, an estimated $220K.
  • Neuberger Berman Canada first reported a position in Charles River Laboratories in Q2 2013 and held it in 1 quarter.
  • Neuberger Berman Canada's Charles River Laboratories position peaked at $220K in Q2 2013.
  • 230 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2013.

Based on Neuberger Berman Canada's 13F filing for Q3 2013, filed 25 Oct 2013.